Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/09/045276
CTRI/2022/09/045276
Not yet recruiting
Phase 2

A Study to Evaluate The Pharmacokinetic Aspect Of Basti in Humans- An Exploratory Study

Dr Kusuma H0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Kusuma H
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Kusuma H

Eligibility Criteria

Inclusion Criteria

  • •Individuals fit for Basti

Exclusion Criteria

  • •Individuals having GIT disturbance

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patients
ACTRN12623001088639Western Sydney Local Health District30
Completed
Not Applicable
A study to assess pharmacokinetic interactions by evaluating the effect of red ginseng in healthy Korean adultsSymptoms, signs and abnormal clinical and laboratory findings, NEC
KCT0002418Kyungpook National University Hospital15
Active, not recruiting
Not Applicable
An Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza during Lactation. - Observational PK studyactating women who present with clinical symptoms indicative of influenza will be recruited to receive immediate treatment with oseltamivir at a standard dose of 75 mg twice daily. These subjects will have a 12 hour pharmacokinetic plasma, urine and breast milk study undertaken after the steady state in oseltamivir concentrations (both active and inactive metabolites will be measured) is reached in blood, i.e. after three days after treatment.MedDRA version: 12.1Level: LLTClassification code 10022000Term: Influenza
EUCTR2010-019372-72-HUPharmahungary Group
Not yet recruiting
Not Applicable
A Clinical Trial for Evaluation of Pharmacokinetic interaction between WS1313D and NAC after Co-administration in Healthy Male Adult SubjectsDiseases of the nervous system
KCT0004878Woosung Pharma27
Active, not recruiting
Not Applicable
A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 DiabetesType I diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitus
EUCTR2008-008306-43-DEovo Nordisk A/S